Antibiotic profile | No. of AB groups | No of phenotypes (%) | No. of AB showing resistance | MARI |
---|---|---|---|---|
PRL/AMC/ATM/FOX/CTX/CAZ/CIP/TS/AK | 4 | 1 (5.9%) | 9 | 0.82 |
PRL/AMC/ATM/CTX/CAZ/CIP/TS/GM/AK | 4 | 2 (11.8%) | 9 | 0.82 |
PRL/AMC/FOX/CTX/CAZ/CIP/TS/GM/AK | 4 | 1 (5.9%) | 9 | 0.82 |
PRL/AMC/FOX/CIP/TS/GM | 4 | 1 (5.9%) | 6 | 0.55 |
PRL/FOX/CTX/CAZ/CIP/TS/GM/AK | 4 | 1 (5.9%) | 8 | 0.73 |
PRL/CTX/CAZ/CIP/TS/GM/AK | 4 | 2 (11.8%) | 7 | 0.64 |
PRL/CTX/CAZ/CIP/GM/AK | 4 | 1 (5.9%) | 6 | 0.55 |
AMC/FOX/TS/AK | 4 | 1 (5.9%) | 4 | 0.36 |
ATM/FOX/CTX/CAZ/CIP/TS/GM/AK | 4 | 3 (17.6%) | 8 | 0.73 |
AMC/FOX/CTX/TS/GM | 3 | 1 (5.9%) | 5 | 0.45 |
AMC/TS/GM | 3 | 2 (11.8%) | 3 | 0.27 |
PRL/ TS/GM | 3 | 1 (5.9%) | 3 | 0.27 |